Plus Therapeutics, Inc.

PSTVNASDAQHealthcare

$3.56-0.34(-8.60%)

$3.2552-Week Range$30.50

Mkt Cap$9M

P/E—

EPS—

Div Yield—

Volume574K

Monitoring…

Plus Therapeutics, Inc. (PSTV) Overview

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

Plus Therapeutics, Inc. operates in the Healthcare sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for PSTV.

Healthcare Earnings History Insider Trading Stock Screener

Pulse Score

D44.0/100

Value

7/20

Growth

7.5/20

Health

10/20

Momentum

9.5/20

Sentiment

10/20

AI Quick Take

AI analysis is being generated. Visit the AI Intel tab for detailed analysis.

Price Trend (30D)

52W Low: $3.2552W High: $30.50

Analyst Consensus

Buy 9Hold 2Sell 0

Target: $1.00(-71.9%)

Earnings Track Record

May 26

Miss +0.0%

Mar 26

Miss -11.1%

Oct 25

Miss -100.0%

Aug 25

Beat +88.9%

Latest Signals

Sims sold 38K shares

4d ago

Sims sold 29K shares

4d ago

How Much Would You Have if You Had Invested $2,000...

17h ago

Tech Corner: AAPL Builds Up Tech Ecosystem

18h ago

Key Statistics

Market Cap

$8.6M

P/E Ratio

-1.8

EPS

$-0.04

Volume

574K

Avg Volume

—

Open

$3.75

Prev. Close

$3.90

Day Range

$3.30 - $3.81

50-Day Avg

$6.49

200-Day Avg

$11.41

52W High

$30.50

52W Low

$3.25

$3.2552-Week Range$30.50

Price Performance

-8.6%

-37.7%

-52.1%

-74.6%

-80.5%

YTD

-74.4%

-82.8%

-96.3%

-99.6%

Growth Rates (YoY)

Revenue

-10.5%

Net Income

-72.5%

EPS

100.0%

Free Cash Flow

-94.8%

FY 2025 vs FY 2024

Shares & Float

Outstanding

2.4M

Float

2.4M

Free Float

99.8%

Earnings Track Record

✗

Aug 24

-34.0%

✓

Nov 24

+34.2%

✗

Mar 25

-31.4%

✗

May 25

-125.7%

✓

Aug 25

+88.9%

✗

Oct 25

-100.0%

✗

Mar 26

-11.1%

—

May 26

Beat estimates 6 of 15 quarters (40%)

About

CEO

Marc H. Hedrick

Sector

Healthcare

Industry

Biotechnology

Website

plustherapeutics.com

Recent SEC Filings

8-K

2026-04-02

2026-04-01

DEF 14A

2026-03-31

8-K

2026-03-26

Latest Plus Therapeutics, Inc. News

How Much Would You Have if You Had Invested $2,000 In Apple When It Went Public?

The Motley Fool·17h ago

Tech Corner: AAPL Builds Up Tech Ecosystem

Schwab Network·18h ago

Apple's 50th Anniversary Was April 1. Is the Tech Giant's Stock Worth Buying and Holding for Another 50 Years?

The Motley Fool·21h ago

The Fed Held Rates Again: Why Long-Term Investors May Not Need to Do Anything

The Motley Fool·21h ago

Apple at 50: The iPhone maker 'blew a 5-year lead' on AI, but former insiders say it can still win

CNBC·23h ago

2,057 Shares in Apple Inc. $AAPL Acquired by Demming Financial Services Corp ADV

Defense World·1d ago

Apple Inc. $AAPL Stake Increased by Stableford Capital II LLC

Defense World·1d ago

Signal Advisors Wealth LLC Acquires 50,263 Shares of Apple Inc. $AAPL

Defense World·1d ago

Financial Summary

ExchangeNASDAQ Capital Market

CIK0001095981

ISINUS72941H8060

CUSIP72941H806

Market Cap$8.6M

Beta1.023

Employees21

Phone737 255 7194

Address4200 Marathon Boulevard, Austin

CountryUS

IPO Date2001-07-11

AI Summary Hub

StoxPulse AI results for PSTV: Pulse Score 44/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.

Plus Therapeutics, Inc.